Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Immunologic Research
Published in: Immunologic Research 6/2021

01-12-2021 | Schizophrenia | Original Article

Association between TLR2 polymorphisms (− 196–174 Ins/Del, R677W, R753Q, and P631H) and schizophrenia in a Tunisian population

Authors: Youssef Aflouk, Oumaima Inoubli, Hana Saoud, Ferid Zaafrane, Lotfi Gaha, Besma Bel Hadj Jrad

Published in: Immunologic Research | Issue 6/2021

Login to get access

Abstract

Since immune dysregulation has been well studied in schizophrenia pathophysiology, recent studies showed a potent role of TLR2 in neuroinflammation process underlying schizophrenia pathogenesis. However, the genetic predisposition is still unclear. Thus, we hypothesized that TLR2 polymorphisms − 196–174 Ins/Del (rs111200466), R753Q (rs5743708), R677W (rs121917864), and P631H (rs5743704) could be involved in schizophrenia predisposition. A case–control study was performed on a Tunisian population composed of 250 healthy controls and 250 patients genotyped by PCR–RFLP. Genotype and allele distribution were evaluated with sex, schizophrenia subtypes, and other clinical features. We also assessed a haplotype analysis for TLR2 polymorphisms with schizophrenia. Our results showed higher ins/del genotype frequency in healthy women compared to patients (p = 0.006; OR = 0.2). In the other hand, logistic regression showed higher ins/del genotype frequency in controls compared to paranoid patients (p = 0.05; OR = 0.48, adjusted). Frequencies of CT and T allele of R677W were significantly higher in patients compared to controls (p < 10−4, OR = 10.39; p < 10−4, OR = 4, adjusted, respectively). R753Q polymorphism was exclusively detected in patients (GA + AA = 2.5%) particularly in men with disorganized subtype. P631H did not show any association with schizophrenia. Finally, haplotype analysis showed that InsGTC and delGTC were associated with higher risk of schizophrenia (p = 0.0001, OR = 8.58; p = 0.04, OR = 5.01, respectively). In the Tunisian population, our results suggested that TLR2 R677W could be associated with susceptibility for schizophrenia, while − 196–174 Ins/Del suggested a trend of protection in women. Otherwise, R753Q could have an effect on schizophrenia especially for disorganized subgroup.
Literature
1.
Owen MJ, Sawa A, Mortensen PB. Schizophrenia. 2016;388:86–97.
2.
McGrath J, Saha S, Chant D, Welham J. Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67–6.
3.
Douki S, Nacef F, Ben zineb S, Ben Amor C. Schizophrénie et culture : réalités et perspectives à partir de l’expérience tunisienne. Encephale. 2007;33(1):21–9.
4.
Bell CC. DSM-IV: diagnostic and statistical manual of mental disorders. JAMA J Am Med Assoc. 1994;272:828.CrossRef
5.
Ayhan Y, McFarland R, Pletnikov MV. Animal models of gene-environment interaction in schizophrenia: A dimensional perspective. Prog Neurobiol. 2016;136:1–27.
6.
Misiak B, Stramecki F, Gawęda Ł, Prochwicz K, Sąsiadek MM, Moustafa AA, et al. Interactions between variation in candidate genes and environmental factors in the etiology of schizophrenia and bipolar disorder: a systematic review. Mol Neurobiol. 2018;55:5075–100.PubMedCrossRef
7.
Allswede DM, Cannon TD. Prenatal inflammation and risk for schizophrenia: a role for immune proteins in neurodevelopment. Dev Psychopathol. 2018;30:1157–78.PubMedCrossRef
8.
Comer AL, Carrier M, Tremblay M-È, Cruz-Martín A. The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation. Front Cell Neurosci. 2020;14:274.PubMedPubMedCentralCrossRef
9.
Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70:663–71.PubMedPubMedCentralCrossRef
10.
Brown AS, Vinogradov S, Kremen WS, Poole JH, Deicken RF, Penner JD, et al. Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatry. 2009;166:683–90.PubMedPubMedCentralCrossRef
11.
Gilmore JH, Jarskog LF, Vadlamudi S, Lauder JM. Prenatal infection and risk for schizophrenia: IL-1β, IL-6, and TNFα inhibit cortical neuron dendrite development. Neuropsychopharmacology. 2004;29(7):1221–9.
12.
Gilmore JH, Jarskog LF. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res. 1997;24:365–7.PubMedCrossRef
13.
Hagberg H, Gressens P, Mallard C. Inflammation during fetal and neonatal life: Implications for neurologic and neuropsychiatric disease in children and adults. Ann Neurol. 2012;71(4):444–57.
14.
Hagberg H, Mallard C, Jacobsson B. Role of cytokines in preterm labour and brain injury. BJOG An Int J Obstet Gynaecol. 2005;112(Suppl 1):16–8.
15.
Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004;61:774–80.PubMedCrossRef
16.
Brown AS, Cohen P, Harkavy-Friedman J, Babulas V, Malaspina D, Gorman JM, et al. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry. 2001;49:473–86.PubMedCrossRef
17.
Gumusoglu SB, Stevens HE. Maternal inflammation and neurodevelopmental programming: A review of preclinical outcomes and implications for translational psychiatry. Biol Psychiatry. 2019;85(2):107–21.
18.
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801.
19.
20.
21.
Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 2004;173:3916–24.PubMedCrossRef
22.
Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol. 2005;175:4320–30.PubMedCrossRef
23.
Bsibsi M, Ravid R, Gveric D, Van Noort JM. Broad expression of toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 2002;61:1013–21.PubMedCrossRef
24.
Dzamko N, Gysbers A, Perera G, Bahar A, Shankar A, Gao J, et al. Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology. Acta Neuropathol. 2017;133:303–19.PubMedCrossRef
25.
Bsibsi M, Nomden A, van Noort JM, Baron W. Toll-like receptors 2 and 3 agonists differentially affect oligodendrocyte survival, differentiation, and myelin membrane formation. J Neurosci Res. 2012;90:388–98.PubMedCrossRef
26.
Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R, et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol. 2007;9:1081–8.PubMedCrossRef
27.
Okun E, Griffioen KJ, Gen Son T, Lee JH, Roberts NJ, Mughal MR, et al. TLR2 activation inhibits embryonic neural progenitor cell proliferation. J Neurochem. 2010;114:462–74.PubMedPubMedCentralCrossRef
28.
Kielian T, Esen N, Bearden ED. Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia. Glia. 2005;49:567–76.PubMedPubMedCentralCrossRef
29.
van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, et al. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry. 2008;64:820–2.PubMedCrossRef
30.
Monji A, Kato TA, Mizoguchi Y, Horikawa H, Seki Y, Kasai M, et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuro-Psychopharmacology Biol Psychiatry. 2013;42:115–21.CrossRef
31.
Howes OD, McCutcheon R. Inflammation and the neural diathesis-stress hypothesis of schizophrenia: A reconceptualization. Transl Psychiatry. 2017;7(2):e1024.
32.
Kozłowska E, Agier J, Wysokiński A, Łucka A, Sobierajska K, Brzezińska-Błaszczyk E. The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia. Psychiatry Res. 2019;272:540–50.PubMedCrossRef
33.
Kéri S, Szabó C, Kelemen O. Antipsychotics influence toll-like receptor (TLR) expression and its relationship with cognitive functions in schizophrenia. Brain Behav Immun. 2017;62:256–64.PubMedCrossRef
34.
McKernan DP, Dennison U, Gaszner G, Cryan JF, Dinan TG. Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype. Transl Psychiatry. 2011;1:e36.PubMedPubMedCentralCrossRef
35.
Texereau J, Chiche JD, Taylor W, Choukroun G, Comba B, Mira JP. The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis. 2005;41(Suppl 7):S408–15.
36.
Lien Y-J, Tsuang H-C, Chiang A, Liu C-M, Hsieh MH, Hwang T-J, et al. The multidimensionality of schizotypy in nonpsychotic relatives of patients with schizophrenia and its applications in ordered subsets linkage analysis of schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:1–9.PubMed
37.
Park SJ, Lee JY, Kim SJ, Choi S-Y, Yune TY, Ryu JH. Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice. Sci Rep. 2015;5:8502.PubMedPubMedCentralCrossRef
38.
Kang WS, Park JK, Lee SM, Kim SK, Park HJ, Kim JW. Association between genetic polymorphisms of toll-like receptor 2 (TLR2) and schizophrenia in the Korean population. Gene. 2013;526:182–6.PubMedCrossRef
39.
Oliveira J, Hamdani N, Busson M, Etain B, Bennabi M, Amokrane K, et al. Association between toll-like receptor 2 gene diversity and early-onset bipolar disorder. J Affect Disord. 2014;165:135–41.PubMedCrossRef
40.
Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki M, et al. An association study of asthma and total serum immunoglobin E levels for toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy. 2004;34:177–83.PubMedCrossRef
41.
Junpee A, Tencomnao T, Sanprasert V, Nuchprayoon S. Association between toll-like receptor 2 (TLR2) polymorphisms and asymptomatic bancroftian filariasis. Parasitol Res. 2010;107:807–16.PubMedCrossRef
42.
Kormann MSD, Ferstl R, Depner M, Klopp N, Spiller S, Illig T, et al. Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk. Allergy. 2009;64:636–42.PubMedCrossRef
43.
Pattabiraman G, Panchal R, Medvedev AE. The R753Q polymorphism in toll-like receptor 2 (TLR2) attenuates innate immune responses to mycobacteria and impairs MyD88 adapter recruitment to TLR2. J Biol Chem. 2017;292:10685–95.PubMedPubMedCentralCrossRef
44.
Ioana M, Ferwerd B, Plantinga TS, Stappers M, Oosting M, McCall M, et al. Different patterns of toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins. Infect Immun. 2012;80:1917–22.PubMedPubMedCentralCrossRef
45.
Jotic A, Jesic S, Zivkovic M, Tomanovic N, Kuveljic J, Stankovic A. Polymorphisms in Toll-like receptors 2 and 4 genes and their expression in chronic suppurative otitis media. Auris Nasus Larynx. 2015;42(6):431–7.
46.
Schröder NWJ, Hermann C, Hamann L, Göbel UB, Hartung T, Schumann RR. High frequency of polymorphism Arg753Gln of the toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med. 2003;81:368–72.PubMedCrossRef
47.
Proença MA, De Oliveira JG, Cadamuro ACT, Succi M, Netinho JG, Goloni-Bertolo EM, et al. TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer. World J Gastroenterol. 2015;21:7730–41.PubMedPubMedCentralCrossRef
48.
Greene JA, Sam-Agudu N, John CC, Opoka RO, Zimmerman PA, Kazura JW. Toll-like receptor polymorphisms and cerebral malaria: TLR2 Δ22 polymorphism is associated with protection from cerebral malaria in a case control study. Malar J. 2012;11:1–19.CrossRef
49.
Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V, et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry. 2004;161:889–95.PubMedCrossRef
50.
Ellman LM, Deicken RF, Vinogradov S, Kremen WS, Poole JH, Kern DM, et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res. 2010;121:46–54.PubMedPubMedCentralCrossRef
51.
Yamamoto T, Tsutsumi N, Tochio H, Ohnishi H, Kubota K, Kato Z, et al. Functional assessment of the mutational effects of human IRAK4 and MyD88 genes. Mol Immunol. 2014;58:66–76.PubMedCrossRef
52.
Larsson MK, Schwieler L, Goiny M, Erhardt S, Engberg G. Chronic antipsychotic treatment in the rat – effects on brain interleukin-8 and kynurenic acid. Int J Tryptophan Res. 2015;8:49–52.PubMedPubMedCentralCrossRef
53.
Nischalke HD, Coenen M, Berger C, Aldenhoff K, Müller T, Berg T, et al. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis. C Int J Cancer. 2012;130:1470–5.CrossRef
54.
Ben Afia A, Aflouk Y, Saoud H, Zaafrane F, Gaha L, BelHadj Jrad B. Inteurleukin-8 gene variations and the susceptibility to schizophrenia. Psychiatry Res. 2020;293:113421.PubMedCrossRef
55.
Kang T-J, Chae G-T. Detection of toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol. 2001;31:53–8.PubMedCrossRef
56.
Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Tuomanen EI, editor Infect Immun. 2000;68:6398–401.CrossRef
57.
Xiong Y, Song C, Snyder GA, Sundberg EJ, Medvedev AE. R753Q polymorphism inhibits toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88. J Biol Chem. 2012;287:38327–37.PubMedPubMedCentralCrossRef
58.
Bochud P-Y, Hawn TR, Aderem A. Cutting edge: a toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol. 2003;170:3451–4.PubMedCrossRef
59.
Kang T-J, Chung EY, Byoung CK, You EY, Chae GT. Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a toll-like receptor 2 mutation. Immunology. 2004;112:674–80.PubMedPubMedCentralCrossRef
60.
Brown RA, Gralewski JH, Eid AJ, Knoll BM, Finberg RW, Razonable RR. R753Q Single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis c virus core and nonstructural 3 proteins. Transplantation. 2010;89:811–5.PubMedPubMedCentralCrossRef
61.
Mrabet-Dahbi S, Dalpke AH, Niebuhr M, Frey M, Draing C, Brand S, et al. The toll-like receptor 2 R753Q mutation modifies cytokine production and toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol. 2008;121:1013–9.PubMedCrossRef
62.
Ben-Ali M, Corre B, Manry J, Barreiro LB, Quach H, Boniotto M, et al. Functional characterization of naturally occurring genetic variants in the human TLR1-2-6 gene family. Hum Mutat. 2011;32:643–52.PubMedCrossRef
63.
Schröder NWJ, Diterich I, Zinke A, Eckert J, Draing C, Baehr VV, et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage lyme disease. J Immunol. 2005;175:2534–40.PubMedCrossRef
64.
Thabet S, Ben Nejma M, Zaafrane F, Gaha L, Ben Salem K, Romdhane A, et al. Association of the Met-196-Arg variation of human tumor necrosis factor receptor 2 (TNFR2) with paranoid schizophrenia. J Mol Neurosci. 2011;43:358–63.PubMedCrossRef
65.
Jemli A, Inoubli O, Trifa F, Mechri A, Zaafrane F, Gaha L, et al. IFNGR2 genetic polymorphism associated with sex-specific paranoid schizophrenia risk. Nord J Psychiatry. 2017;71:42–7.PubMedCrossRef
66.
Inoubli O, Jemli A, Ben Fredj S, Mechri A, Gaha L, BelHadj Jrad B. Haplotypes of TNFα/β genes associated with sex-specific paranoid schizophrenic risk in tunisian population. Dis Markers. 2018;2018:3502564.PubMedPubMedCentralCrossRef
67.
Orhan F, Bhat M, Sandberg K, Ståhl S, Piehl F, Svensson C, et al. Tryptophan metabolism along the kynurenine pathway downstream of toll-like receptor stimulation in peripheral monocytes. Scand J Immunol. 2016;84:262–71.PubMedCrossRef
68.
Capuron L, Schroecksnadel S, Féart C, Aubert A, Higueret D, Barberger-Gateau P, et al. Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry. 2011;70:175–82.PubMedCrossRef
69.
Miller CL, Llenos IC, Dulay JR, Weis S. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain Res. 2006;1073–1074:25–37.PubMedCrossRef
70.
Erhardt S, Schwieler L, Imbeault S, Engberg G. The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology. 2017;112:297–306.PubMedCrossRef
71.
Muller N, Myint A-M, Schwarz J, Kynurenine M. Pathway in schizophrenia: pathophysiological and therapeutic aspects. Curr Pharm Des. 2011;17:130–6.PubMedCrossRef
72.
Bulzacka E, Boyer L, Schürhoff F, Godin O, Berna F, Brunel L, et al. Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset. Schizophr Bull. 2016;42:1290–302.PubMedPubMedCentralCrossRef
73.
Fernandes BS, Steiner J, Bernstein H-G, Dodd S, Pasco JA, Dean OM, et al. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol Psychiatry. 2016;21:554–64.PubMedCrossRef
74.
Hussein YM, Awad HA, Shalaby SM, Ali A-SA, Alzahrani SS. Toll-like receptor 2 and toll-like receptor 4 polymorphisms and susceptibility to asthma and allergic rhinitis: a case–control analysis. Cell Immunol. 2012;274:34–8.PubMedCrossRef
75.
Yu J-T, Sun Y-P, Ou J-R, Cui W-Z, Zhang W, Tan L. No association of toll-like receptor 2 polymorphisms with Alzheimer’s disease in Han Chinese. Neurobiol Aging. 2011;32:1924.e1-1924.e3.CrossRef
76.
Ryu YJ, Kim EJ, Koh WJ, Kim H, Kwon OJ, Chang JH. Toll-like receptor 2 polymorphisms and nontuberculous mycobacterial lung diseases. Clin Vaccine Immunol. 2006;13:818–9.PubMedPubMedCentralCrossRef
77.
Folwaczny M, Glas J, Török HP, Limbersky O, Folwaczny C. Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin Exp Immunol. 2004;135:330–5.PubMedPubMedCentralCrossRef
78.
Biswas D, Gupta SK, Sindhwani G, Patras A. TLR2 polymorphisms, Arg753Gln and Arg677Trp, are not associated with increased burden of tuberculosis in Indian patients. BMC Res Notes. 2009;2:162.PubMedPubMedCentralCrossRef
79.
Saleh MA, Ramadan MM, Arram EO. Toll-like receptor-2 Arg753Gln and Arg677Trp polymorphisms and susceptibility to pulmonary and peritoneal tuberculosis. APMIS. 2017;125(6):558–64.
80.
Moumad K, Lascorz J, Bevier M, Khyatti M, Ennaji MM, Benider A, et al. Genetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa. G3 Genes Genomes Genet. 2013;3:971–7.
81.
Cédola M, Chiani Y, Pretre G, Alberdi L, Vanasco B, Gómez RM. Association of toll-like receptor 2 Arg753Gln and toll-like receptor 1 Ile602Ser single-nucleotide polymorphisms with leptospirosis in an argentine population. Acta Trop. 2015;146:73–80.PubMedCrossRef
82.
Matas-Cobos AM, Redondo-Cerezo E, Alegría-Motte C, Martínez-Chamorro A, Saenz-López P, Jiménez P, et al. The role of toll-like receptor polymorphisms in acute pancreatitis occurrence and severity. Pancreas. 2015;44:429–33.PubMedCrossRef
83.
Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol. 2004;11:625–6.PubMedPubMedCentral
84.
Abida O, Bahloul E, Elloumi N, Toumi A, Tahri S, Ben Jmaa M, et al. Toll-like-receptor gene polymorphisms in tunisian endemic Pemphigus Foliaceus. Kanazawa N editor Biomed Res Int. 2020;2020:6541761.
85.
Dhifallah Ben I, Lachheb J, Houman H, Hamzaoui K. Toll-like-receptor gene polymorphisms in a Tunisian population with Behçet’s disease. Clin Exp Rheumatol. 2009;27:S58-62.
86.
Ajili F, Boubaker S, Derouiche A, Ali Ben M, Mustapha Ben I, Cherif M, et al. Relationship between toll-like receptor 2 nonsynonymous single nucleotide polymorphisms and the effectiveness of Bacille Calmette-Guérin immunotherapy in preventing recurrence of superficial bladder cancer: a prospective study. Curr Ther Res Clin Exp. 2010;71:398–407.PubMedPubMedCentralCrossRef
87.
Lachheb J, Dhifallah IB, Chelbi H, Hamzaoui K, Hamzaoui A. Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children. Tissue Antigens. 2008;71:417–25.PubMedCrossRef
88.
Rosentul DC, Delsing CE, Jaeger M, Plantinga TS, Oosting M, Costantini I, et al. Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis. Front Microbiol. 2014;5:483.PubMedPubMedCentralCrossRef
Metadata
Title
Association between TLR2 polymorphisms (− 196–174 Ins/Del, R677W, R753Q, and P631H) and schizophrenia in a Tunisian population
Authors
Youssef Aflouk
Oumaima Inoubli
Hana Saoud
Ferid Zaafrane
Lotfi Gaha
Besma Bel Hadj Jrad
Publication date
01-12-2021
Publisher
Springer US
Keyword
Schizophrenia
Published in
Immunologic Research / Issue 6/2021
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-021-09238-9

Other articles of this Issue 6/2021

Immunologic Research 6/2021 Go to the issue

Review

Chimeric antigen receptor (CAR) immunotherapy: basic principles, current advances, and future prospects in neuro-oncology

Original Article

Serum decoy receptor 3 (DcR3): a promising biomarker for atopic asthma in children

Original Article

COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells

Original Article

Disrupted homeostasis of synovial hyaluronic acid and its associations with synovial mast cell proteases of rheumatoid arthritis patients and collagen-induced arthritis rats

Original Article

Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae?

Brief Report

Asfotase Alfa hypersensitivity: an outpatient 8-steps desensitization protocol